Evidence map›Paper›PMID 29541859›Full record

ArticleJournal of cancer research and clinical oncology2018

Ovarian metastasis in patients with endometrial cancer: risk factors and impact on survival.

Tanja Ignatov, Holm Eggemann, Elke Burger, Olaf Ortmann, Serban Dan Costa, Atanas Ignatov

Abstract readMulticenter Study
In one paragraph

Article in Journal of cancer research and clinical oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Elevated CA-125 Level and ER-Negative as Prognostic Factors for Ovarian Metastasis in Patients with Endometrial Cancer: A Retrospective Cohort Study.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tanja IgnatovDepartment of Gynecology and Obstetrics, Otto-von-Guericke University, G.-Hauptmann Str. 35, 39108, Magdeburg, Germany.
Holm EggemannDepartment of Gynecology and Obstetrics, Otto-von-Guericke University, G.-Hauptmann Str. 35, 39108, Magdeburg, Germany.
Elke BurgerInstitute of Biometry and Medical Informatics, Otto-von-Guericke University, Magdeburg, Germany.
Olaf OrtmannDepartment of Gynecology and Obstetrics, University Medical Center Regensburg, Regensburg, Germany.
Serban Dan CostaDepartment of Gynecology and Obstetrics, Otto-von-Guericke University, G.-Hauptmann Str. 35, 39108, Magdeburg, Germany.
Atanas IgnatovDepartment of Gynecology and Obstetrics, Otto-von-Guericke University, G.-Hauptmann Str. 35, 39108, Magdeburg, Germany. atanas.ignatov@gmail.com.ORCID http://orcid.org/0000-0002-9006-4029

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOophorectomy is generally performed in patients with endometrial cancer despite the rate of ovarian metastasis being relatively low. PATIENTS AND

methodsA multicenter retrospective registry-based study was performed in 2329 patients with endometrial cancer. The outcome measures were the incidence of ovarian metastasis and the impact on overall survival.

resultsMedian follow-up was performed at 84 months. A total of 2158 women were eligible for analysis, of which 131 (6.1%) had ovarian metastasis. Women with ovarian metastasis were more likely to have > 50% myometrial invasion, undifferentiated nonendometrioid tumors, and lymph and vascular space invasion. The presence of < 50% myometrial invasion, endometrioid histology, well-differentiated cancer, and negative lymph and vascular space invasion were associated with a very low rate (0.5%) of ovarian metastasis. Notably, after matching for tumor histology and grade, myometrial invasion, and lymph and vascular space invasion, ovarian metastasis was not associated with a reduced median overall survival.

conclusionsOvarian preservation should be offered to premenopausal women with endometrial cancer in whom myometrial invasion is less than 50%, the histological type is endometrioid and well-differentiated, and lymph and vascular space invasion is not involved.

Indexed as

AdultAgedAged, 80 and overCohort StudiesEndometrial NeoplasmsFemaleGermanyHumansMiddle AgedOvarian NeoplasmsRetrospective StudiesRisk FactorsEndometrial cancerMetastasisOvarian

Identifiers

PMID29541859
PMCPMC11813296

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.